| URL | https://themedicinemaker.com/discovery-development |
| Source | The Medicine Maker |
| Date Published | 05/22/2023 |
| Author Name | Jamie Irvine |
| Company/Division name | Thermo Fisher Scientific |
| Parent company | Thermo Fisher Scientific |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2021 |
| City reshored to: | Mission Bay |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell therapy cGMP manufacturing |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies, Higher productivity, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training |